PTC THERAPEUTICS INC (PTCT:NASDAQ)
$84.85 -4.7 (-5.2485%)
Analysed PTC THERAPEUTICS INC (PTCT:NASDAQ) News Sources
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
16-06-2026
yahoo.com
This Biotech Stock Is Surging 81% on Surprise Good News From FDA
17-06-2026
yahoo.com
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-06-2026
yahoo.com
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
18-06-2026
yahoo.com
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
02-07-2026
yahoo.com
PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should Know
08-07-2026
yahoo.com
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
10-07-2026
yahoo.com
Immunome Stock Up 32% in a Month: Here's What You Should Know
10-07-2026
yahoo.com
Is PTC Therapeutics (PTCT) A Bargain Following Its Russell 2000 Defensive Index Additions?
10-07-2026
yahoo.com
PTC Therapeutics (PTCT) Stock May Be Fully Priced After Rare Disease Data
11-07-2026
yahoo.com
What is the current price of PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The current price of PTC THERAPEUTICS INC (PTCT:NASDAQ) is $84.85.
PTC THERAPEUTICS INC (PTCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PTC THERAPEUTICS INC (PTCT:NASDAQ) since the previous trading day is $-4.7.
PTC THERAPEUTICS INC (PTCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PTC THERAPEUTICS INC (PTCT:NASDAQ) since the previous trading day is -5.2485%.
What is the most recent average sentiment score for PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The most recent average sentiment score for PTC THERAPEUTICS INC (PTCT:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The most recent sentiment for PTC THERAPEUTICS INC (PTCT:NASDAQ) is .
SEC-8K** Filing Available For PTC THERAPEUTICS INC (PTCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.